ANTI.US Antigenics Inc

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is ANTI.US undervalued?

Graham number

The Graham number of Antigenics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Antigenics Inc fundamental analysis

No fundamental analysis for Antigenics Inc yet.

Antigenics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Antigenics Inc

Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.

Full company profile